Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease

Abstract

This is a unique report of two cases of patients with end-stage renal disease on hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity of safety and efficacy data in this patient subgroup.